NPHP3-AS1: A Potential Drug Target and Biomarker (G348808)

Target Name: NPHP3-AS1

NCBI ID: G348808

NPHP3-AS1

Other Name(s): NPHP3 antisense RNA 1 | NCRNA00119 | NPHP3 antisense RNA 1, transcript variant 1

NPHP3-AS1: A Potential Drug Target and Biomarker

NPHP3-AS1, also known as NPHP3 antisense RNA 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. NPHP3-AS1 is a 22-nt RNA molecule that is highly conserved across various species, including humans. It is expressed in various tissues and cells of the body and is involved in various cellular processes, including cell signaling, metabolism, and stress response.

The discovery of NPHP3-AS1 as a potential drug target and biomarker has significant implications for the development of new therapeutic strategies for various diseases. NPHP3-AS1 has been shown to play a critical role in the regulation of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

One of the key features of NPHP3-AS1 is its ability to interact with various proteins, including tyrosine kinases, histone-modifying enzymes, and transcription factors. This interaction between NPHP3-AS1 and these proteins suggests that NPHP3-AS1 may be a useful target for small molecules that can modulate its activity.

In addition to its potential as a drug target, NPHP3-AS1 has also been shown to be a potential biomarker for various diseases. For example, NPHP3-AS1 has been shown to be downregulated in various cancer tissues and has been used as a biomarker for cancer diagnosis and treatment. Additionally, NPHP3-AS1 has been shown to be elevated in the blood of individuals with neurodegenerative diseases, such as Alzheimer's disease, and has been used as a biomarker for neurodegenerative diseases.

The potential utility of NPHP3-AS1 as a drug target and biomarker makes it an attractive target for researchers to investigate its effects on various diseases. One potential approach to modulating NPHP3-AS1 activity is through the use of small molecules that can interact with its interacting proteins. This approach is still in its early stages, but it holds great promise as a means of developing new therapeutic strategies for various diseases.

In conclusion, NPHP3-AS1 is a non-coding RNA molecule that has significant implications as a potential drug target and biomarker. Its ability to interact with various proteins and its potential as a target for small molecules make it an attractive target for researchers to investigate its effects on various diseases. Further research is needed to fully understand the role of NPHP3-AS1 in cellular processes and its potential as a drug and biomarker.

Protein Name: NPHP3 Antisense RNA 1

The "NPHP3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPHP3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets